J. Walz to Follow-Up Studies
This is a "connection" page, showing publications J. Walz has written about Follow-Up Studies.
Connection Strength
0.138
-
Walz J, Chun FK, Klein EA, Reuther A, Graefen M, Huland H, Karakiewicz PI. Risk-adjusted hazard rates of biochemical recurrence for prostate cancer patients after radical prostatectomy. Eur Urol. 2009 Feb; 55(2):412-19.
Score: 0.051
-
Walz J, Suardi N, Hutterer GC, Perrotte P, Gallina A, B?nard F, Valiquette L, McCormack M, Graefen M, Montorsi F, Karakiewicz PI. Lower urinary tract symptoms affect one-third of men in a prostate cancer screening population. J Endourol. 2008 Feb; 22(2):369-76.
Score: 0.048
-
Suardi N, Larcher A, Haese A, Ficarra V, Govorov A, Buffi NM, Walz J, Rocco B, Borghesi M, Steuber T, Pini G, Briganti A, Mottrie AM, Guazzoni G, Montorsi F, Pushkar D, Van Der Poel H. Indication for and extension of pelvic lymph node dissection during robot-assisted radical prostatectomy: an analysis of five European institutions. Eur Urol. 2014 Oct; 66(4):635-43.
Score: 0.018
-
Gallina A, Jeldres C, Chun FK, Shariat SF, Briganti A, Walz J, Roehrborn CG, Saad F, Huland H, Graefen M, Montorsi F, Karakiewicz PI. Prediction of pathological stage is inaccurate in men with PSA values above 20 ng/mL. Eur Urol. 2007 Nov; 52(5):1374-80.
Score: 0.011
-
Rades D, Walz J, Stalpers LJ, Veninga T, Schulte R, Obralic N, Wildfang I, Engenhart-Cabilic R, Hoskin PJ, Schild SE. Short-course radiotherapy (RT) for metastatic spinal cord compression (MSCC) due to renal cell carcinoma: results of a retrospective multi-center study. Eur Urol. 2006 May; 49(5):846-52; discussion 852.
Score: 0.010